Lacunar ischemic stroke
The real cause of a common stroke may have been missed for decades Scientists have discovered that a common type of stroke may have a very different cause than doctors once thought. Instead of fatty plaque clogging arteries, the strongest link was found with enlarged and damaged blood vessels deep within the brain. The finding helps explain why standard treatments like aspirin are often less effective and is driving the search for new therapies that target the brain
Clinical significance
Lacunar ischemic stroke is a small-vessel ischemic stroke caused by occlusion of a penetrating artery, producing a small infarct in deep brain structures such as the basal ganglia, thalamus, internal capsule, brainstem, or deep white matter. The emerging evidence highlighted above points toward intrinsic small-vessel disease—including arteriolar enlargement, wall damage, and impaired vessel function—as an important mechanism, rather than assuming that large-artery atherosclerosis is the primary cause in every case.
Typical presentation
- Sudden, focal neurological deficit without cortical signs such as aphasia, neglect, or visual-field loss.
- Common lacunar syndromes include pure motor hemiparesis, pure sensory stroke, sensorimotor stroke, ataxic hemiparesis, and dysarthria–clumsy hand syndrome.
- Symptoms may be mild initially but can produce substantial disability, particularly when the internal capsule or brainstem is involved.
Major risk factors
- Long-standing hypertension
- Diabetes mellitus
- Smoking
- Dyslipidemia and aging
- Chronic kidney disease and other conditions associated with endothelial or small-vessel injury
Pathophysiology and research direction
The principal pathology traditionally associated with lacunar infarction includes lipohyalinosis and arteriolosclerosis of penetrating arteries. Newer imaging and epidemiological work is examining whether enlarged perivascular spaces, abnormal deep perforating vessels, blood–brain-barrier dysfunction, and impaired cerebrovascular reactivity identify a more specific disease process. These findings may help explain recurrent strokes, cognitive impairment, gait disturbance, and why strategies designed primarily for embolic or large-artery stroke do not address all cases equally.
Evaluation
Evaluation generally includes urgent brain imaging—typically noncontrast CT to exclude hemorrhage and MRI with diffusion-weighted imaging to detect a small acute infarct—along with vascular imaging, cardiac assessment when indicated, and systematic evaluation of vascular risk factors. The presence of a lacunar-appearing infarct does not automatically exclude atrial fibrillation, carotid disease, or another competing mechanism.
Prevention and treatment principles
Acute management follows evidence-based ischemic-stroke protocols, including assessment for reperfusion therapy when eligible. Secondary prevention is individualized and commonly includes rigorous blood-pressure control, diabetes management, lipid lowering, smoking cessation, physical activity, and antithrombotic therapy selected according to the established stroke mechanism. Aspirin and other antiplatelet treatments may reduce risk in appropriate patients, but they do not repair the underlying arteriolar disease; treatment of the small-vessel pathology itself remains an important research goal.
Safety note: This is educational information, not a substitute for urgent medical assessment. New facial droop, arm weakness, speech difficulty, loss of coordination, or sudden numbness requires emergency evaluation immediately.
Open questions
- Which imaging markers best distinguish different forms of lacunar small-vessel disease?
- Can deep perforating-vessel dysfunction be measured reliably in routine clinical practice?
- Which therapies protect the vessel wall and blood–brain barrier, beyond conventional antithrombotic treatment?
- How can prevention strategies reduce both recurrent stroke and vascular cognitive decline?